ACTIVE

PharmaCross

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

503,9 k €

-45.3% YoY

Revenue

18,2 M €

-0.7% YoY

Equity

1,2 M €

-79.9% YoY

What does PharmaCross do?

PharmaCross is a Private limited company incorporated in 2007. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Deinze.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0888.580.475

Incorporation

05/04/2007

Legal form

Private limited company

Registered office

Poeldendries 49
9850 Deinze · FlandreSee on map

Contributed capital

9 780,18 €

Latest accounts

31/12/2025

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Revenue	18,2 M €	-0.7%	18,3 M €	+15.1%	15,9 M €	-13.7%	18,4 M €	-27.4%	25,4 M €	+6.8%	23,8 M €	+38.0%	17,2 M €	+10.5%	15,6 M €	-8.5%	17 M €	-56.2%	38,9 M €	+126%	17,2 M €	+15.1%	15 M €	-3.3%	15,5 M €	+10.5%	14 M €		–		–		–		–
EBITDA	445,5 k €	-67.8%	1,4 M €	+337%	316,5 k €	+3.3%	306,5 k €	-35.8%	477,6 k €	-29.2%	674,5 k €	+60.3%	420,8 k €	-42.0%	725,6 k €	-55.3%	1,6 M €	-53.8%	3,5 M €	+98.9%	1,8 M €	+31.0%	1,3 M €	-1.7%	1,4 M €	-10.3%	1,5 M €	+12.8%	1,4 M €	+631%	185,5 k €	+350%	41,2 k €	+1059%	-4,3 k €
Operating result	444,1 k €	-65.5%	1,3 M €	+482%	220,9 k €	+3.9%	212,7 k €	-44.2%	381,3 k €	-33.7%	574,9 k €	+81.2%	317,2 k €	-48.8%	619,2 k €	-59.2%	1,5 M €	-55.5%	3,4 M €	+103%	1,7 M €	+26.6%	1,3 M €	-1.8%	1,3 M €	-10.5%	1,5 M €	+12.8%	1,3 M €	+680%	171,2 k €	+350%	38,1 k €	+986%	-4,3 k €
Net result	503,9 k €	-45.3%	921,3 k €	+295%	233 k €	+310%	56,9 k €	-79.6%	279 k €	-48.6%	543,1 k €	+39.0%	390,8 k €	-8.2%	425,8 k €	-35.5%	660 k €	-70.0%	2,2 M €	+113%	1 M €	+27.5%	809,8 k €	-5.1%	853,6 k €	-11.5%	964,1 k €	+11.2%	867 k €	+690%	109,8 k €	+310%	26,8 k €	+716%	-4,3 k €
Balance sheet
Equity	1,2 M €	-79.9%	6,1 M €	+17.7%	5,2 M €	+4.7%	5 M €	-11.2%	5,6 M €	+5.3%	5,3 M €	+11.4%	4,8 M €	+8.9%	4,4 M €	-6.9%	4,7 M €	+16.3%	4 M €	+84.6%	2,2 M €	+45.9%	1,5 M €	+48.5%	1 M €	+23.2%	818,9 k €	+89.2%	432,8 k €	+558%	65,8 k €	+153%	26 k €	+223%	8,1 k €
Total assets	3,3 M €	-55.9%	7,4 M €	+10.6%	6,7 M €	-6.3%	7,2 M €	-25.2%	9,6 M €	-5.0%	10,1 M €	+21.7%	8,3 M €	+24.6%	6,6 M €	-19.2%	8,2 M €	-56.7%	19 M €	+151%	7,6 M €	+13.1%	6,7 M €	+29.1%	5,2 M €	+1.7%	5,1 M €	+6.3%	4,8 M €	+309%	1,2 M €	+285%	304,4 k €	+3584%	8,3 k €
Cash	455,2 k €	-74.2%	1,8 M €	+23.6%	1,4 M €	+13.8%	1,3 M €	-57.3%	2,9 M €	+27.5%	2,3 M €	+79.7%	1,3 M €	-19.9%	1,6 M €	-63.7%	4,4 M €	-38.6%	7,2 M €	+217%	2,3 M €	-44.2%	4,1 M €	+146%	1,6 M €	-47.9%	3,2 M €	+465%	559,2 k €	+739%	66,7 k €	+595%	9,6 k €	+109%	4,6 k €
Debts	2 M €	+56.6%	1,3 M €	-13.8%	1,5 M €	-31.1%	2,2 M €	-44.9%	4 M €	-16.4%	4,8 M €	+35.7%	3,5 M €	+54.7%	2,3 M €	-35.6%	3,5 M €	-76.4%	14,9 M €	+179%	5,4 M €	+3.6%	5,2 M €	+24.4%	4,2 M €	-2.5%	4,3 M €	-2.0%	4,4 M €	+294%	1,1 M €	+297%	278,4 k €	+132585%	209,8 €

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

Danny Vander Cruyssen

Director · since 22 mars 2007

Active

Ended mandates

DANNY VANDER CRUYSSEN

Director

Ended

DANNY VANDER CRUYSSEN

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
EURO - MEDIC● Active	0473.175.601

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/08/2026	15/07/2025	02/07/2024	14/07/2023	13/07/2022	30/08/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	30/06/2023	24/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	26/06/2026	11/08/2026	Dutch	PDF
Full model	31/12/2024	27/06/2025	15/07/2025	Dutch	PDF
Full model	31/12/2023	28/06/2024	02/07/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	14/07/2023	Dutch	PDF
Full model	31/12/2021	24/06/2022	13/07/2022	Dutch	PDF
Full model	31/12/2020	25/06/2021	30/08/2021	Dutch	PDF
Full model	31/12/2019	04/09/2020	01/10/2020	Dutch	PDF
Full model	31/12/2018	28/06/2019	26/08/2019	Dutch	PDF
Full model	31/12/2017	29/06/2018	29/08/2018	Dutch	PDF
Full model	31/12/2016	30/06/2017	17/07/2017	Dutch	PDF
Full model	31/12/2015	10/06/2016	16/06/2016	Dutch	PDF
Full model	31/12/2014	26/06/2015	26/08/2015	Dutch	PDF
Full model	31/12/2013	27/06/2014	29/08/2014	Dutch	PDF
Full model	31/12/2012	29/03/2013	30/08/2013	Dutch	PDF
Abridged model	31/12/2011	20/05/2012	26/07/2012	Dutch	PDF
Abridged model	31/12/2010	10/05/2011	16/05/2011	Dutch	PDF
Abridged model	31/12/2009	25/06/2010	01/07/2010	Dutch	PDF
Abridged model	31/12/2008	26/06/2009	31/08/2009	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

Danny Vander Cruyssen

Director · since 22 mars 2007

Active

Ended mandates

DANNY VANDER CRUYSSEN

Director

Ended

DANNY VANDER CRUYSSEN

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Restructuring08/08/2025
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring27/05/2025
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Other08/06/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN
PDF
Capital / shares21/06/2018
KAPITAAL - AANDELEN
PDF
Capital / shares18/04/2014
KAPITAAL - AANDELEN
PDF
Other16/04/2007
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025503,9 k €↓
2024
Annual accounts 2024921,3 k €↑
2023
Annual accounts 2023233 k €↑
2022
Annual accounts 202256,9 k €↓
2021
Annual accounts 2021279 k €↓
2020
Annual accounts 2020543,1 k €↑
2019
Annual accounts 2019390,8 k €↓
2018
Annual accounts 2018425,8 k €↓
2017
Annual accounts 2017660 k €↓
2016
Annual accounts 20162,2 M €↑
2015
Annual accounts 20151 M €↑
2014
Annual accounts 2014809,8 k €↓
2013
Annual accounts 2013853,6 k €↓
2012
Annual accounts 2012964,1 k €↑
2011
Annual accounts 2011867 k €↑
2010
Annual accounts 2010109,8 k €↑
2009
Annual accounts 200926,8 k €↑
2008
Annual accounts 2008-4,3 k €
05/04/2007
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PharmaCross

Overview

What does PharmaCross do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline